Amberen and Weight Loss: FTC Ruling Reveals Deception
The FTC's Action Against Amberen: A Case Study in Misleading Marketing The Federal Trade Commission (FTC) recently took action against Lunada Biomedical, the maker of the weight-loss supplement Amberen, for deceptive marketing practices. Amberen's advertising, targeting women experiencing menopause, made unsubstantiated claims regarding significant weight loss, particularly belly fat reduction. The FTC's investigation revealed a critical lack of robust scientific evidence to support these claims, leading to a settlement demanding substantial penalties and corrective advertising from Lunada Biomedical....